abstract |
Abstract of the Disclosure The present invention relates generally to methods of using anti-NGF antibodies in 5 the treatment of various NGF-related disorders, including asthma, arthritis and psoriasis. The methods are effective in treating these disorders in a patient without having a significant adverse effect on the immune system of the patient. 4762978_1 (GHMatters) P51344.AU.3 |